Prostate-Specific Antigen (PSA) Test Market Report

Global Prostate-Specific Antigen (PSA) Test Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：171
  • REPORT CODE：GMM875704
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Prostate-Specific Antigen (PSA) Test market report explains the definition, types, applications, major countries, and major players of the Prostate-Specific Antigen (PSA) Test market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • PerkinElmer

    • BodiTech

    • Roche

    • Tosoh

    • DiaSorin

    • Mediwatch (LABORIE)

    • Siemens Healthcare

    • Ortho Clinical

    • Beckman Coulter

    • Fujirebio

    • Abbott

    By Type:

    • CLIA

    • ELISA

    • Other

    By End-User:

    • Screening

    • Post-treatment Monitoring

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Prostate-Specific Antigen (PSA) Test Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Prostate-Specific Antigen (PSA) Test Outlook to 2028- Original Forecasts

    • 2.2 Prostate-Specific Antigen (PSA) Test Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Prostate-Specific Antigen (PSA) Test Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Prostate-Specific Antigen (PSA) Test Market- Recent Developments

    • 6.1 Prostate-Specific Antigen (PSA) Test Market News and Developments

    • 6.2 Prostate-Specific Antigen (PSA) Test Market Deals Landscape

    7 Prostate-Specific Antigen (PSA) Test Raw Materials and Cost Structure Analysis

    • 7.1 Prostate-Specific Antigen (PSA) Test Key Raw Materials

    • 7.2 Prostate-Specific Antigen (PSA) Test Price Trend of Key Raw Materials

    • 7.3 Prostate-Specific Antigen (PSA) Test Key Suppliers of Raw Materials

    • 7.4 Prostate-Specific Antigen (PSA) Test Market Concentration Rate of Raw Materials

    • 7.5 Prostate-Specific Antigen (PSA) Test Cost Structure Analysis

      • 7.5.1 Prostate-Specific Antigen (PSA) Test Raw Materials Analysis

      • 7.5.2 Prostate-Specific Antigen (PSA) Test Labor Cost Analysis

      • 7.5.3 Prostate-Specific Antigen (PSA) Test Manufacturing Expenses Analysis

    8 Global Prostate-Specific Antigen (PSA) Test Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Prostate-Specific Antigen (PSA) Test Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Prostate-Specific Antigen (PSA) Test Export by Region (Top 10 Countries) (2017-2028)

    9 Global Prostate-Specific Antigen (PSA) Test Market Outlook by Types and Applications to 2022

    • 9.1 Global Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CLIA Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global ELISA Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Screening Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Post-treatment Monitoring Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Prostate-Specific Antigen (PSA) Test Market Analysis and Outlook till 2022

    • 10.1 Global Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.2.2 Canada Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.2.3 Mexico Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.2 UK Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.3 Spain Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.4 Belgium Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.5 France Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.6 Italy Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.7 Denmark Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.8 Finland Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.9 Norway Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.10 Sweden Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.11 Poland Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.12 Russia Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.3.13 Turkey Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.2 Japan Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.3 India Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.4 South Korea Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.5 Pakistan Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.6 Bangladesh Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.7 Indonesia Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.8 Thailand Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.9 Singapore Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.10 Malaysia Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.11 Philippines Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.4.12 Vietnam Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.5.2 Colombia Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.5.3 Chile Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.5.4 Argentina Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.5.5 Venezuela Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.5.6 Peru Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.5.7 Puerto Rico Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.5.8 Ecuador Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.6.2 Kuwait Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.6.3 Oman Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.6.4 Qatar Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.7.2 South Africa Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.7.3 Egypt Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.7.4 Algeria Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

      • 10.8.2 New Zealand Prostate-Specific Antigen (PSA) Test Consumption (2017-2022)

    11 Global Prostate-Specific Antigen (PSA) Test Competitive Analysis

    • 11.1 PerkinElmer

      • 11.1.1 PerkinElmer Company Details

      • 11.1.2 PerkinElmer Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.1.4 PerkinElmer Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 BodiTech

      • 11.2.1 BodiTech Company Details

      • 11.2.2 BodiTech Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 BodiTech Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.2.4 BodiTech Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Roche

      • 11.3.1 Roche Company Details

      • 11.3.2 Roche Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Roche Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.3.4 Roche Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Tosoh

      • 11.4.1 Tosoh Company Details

      • 11.4.2 Tosoh Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Tosoh Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.4.4 Tosoh Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 DiaSorin

      • 11.5.1 DiaSorin Company Details

      • 11.5.2 DiaSorin Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 DiaSorin Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.5.4 DiaSorin Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Mediwatch (LABORIE)

      • 11.6.1 Mediwatch (LABORIE) Company Details

      • 11.6.2 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.6.4 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Siemens Healthcare

      • 11.7.1 Siemens Healthcare Company Details

      • 11.7.2 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.7.4 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Ortho Clinical

      • 11.8.1 Ortho Clinical Company Details

      • 11.8.2 Ortho Clinical Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.8.4 Ortho Clinical Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Beckman Coulter

      • 11.9.1 Beckman Coulter Company Details

      • 11.9.2 Beckman Coulter Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.9.4 Beckman Coulter Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Fujirebio

      • 11.10.1 Fujirebio Company Details

      • 11.10.2 Fujirebio Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Fujirebio Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.10.4 Fujirebio Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Abbott

      • 11.11.1 Abbott Company Details

      • 11.11.2 Abbott Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Abbott Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

      • 11.11.4 Abbott Prostate-Specific Antigen (PSA) Test Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Prostate-Specific Antigen (PSA) Test Market Outlook by Types and Applications to 2028

    • 12.1 Global Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global CLIA Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global ELISA Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Screening Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Post-treatment Monitoring Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Prostate-Specific Antigen (PSA) Test Market Analysis and Outlook to 2028

    • 13.1 Global Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.2.2 Canada Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.2 UK Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.3 Spain Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.5 France Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.6 Italy Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.8 Finland Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.9 Norway Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.11 Poland Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.12 Russia Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.2 Japan Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.3 India Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.5.3 Chile Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.5.6 Peru Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.6.3 Oman Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Prostate-Specific Antigen (PSA) Test Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Prostate-Specific Antigen (PSA) Test

    • Figure of Prostate-Specific Antigen (PSA) Test Picture

    • Table Global Prostate-Specific Antigen (PSA) Test Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Prostate-Specific Antigen (PSA) Test Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global CLIA Consumption and Growth Rate (2017-2022)

    • Figure Global ELISA Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Screening Consumption and Growth Rate (2017-2022)

    • Figure Global Post-treatment Monitoring Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate-Specific Antigen (PSA) Test Consumption by Country (2017-2022)

    • Table North America Prostate-Specific Antigen (PSA) Test Consumption by Country (2017-2022)

    • Figure United States Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Canada Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Mexico Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Table Europe Prostate-Specific Antigen (PSA) Test Consumption by Country (2017-2022)

    • Figure Germany Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure UK Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Spain Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Belgium Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure France Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Italy Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Denmark Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Finland Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Norway Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Sweden Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Poland Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Russia Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Turkey Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Table APAC Prostate-Specific Antigen (PSA) Test Consumption by Country (2017-2022)

    • Figure China Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Japan Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure India Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Thailand Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Singapore Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Philippines Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Table South America Prostate-Specific Antigen (PSA) Test Consumption by Country (2017-2022)

    • Figure Brazil Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Colombia Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Chile Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Argentina Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Peru Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Table GCC Prostate-Specific Antigen (PSA) Test Consumption by Country (2017-2022)

    • Figure Bahrain Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Oman Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Qatar Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Table Africa Prostate-Specific Antigen (PSA) Test Consumption by Country (2017-2022)

    • Figure Nigeria Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure South Africa Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Egypt Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure Algeria Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Table Oceania Prostate-Specific Antigen (PSA) Test Consumption by Country (2017-2022)

    • Figure Australia Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Prostate-Specific Antigen (PSA) Test Consumption and Growth Rate (2017-2022)

    • Table PerkinElmer Company Details

    • Table PerkinElmer Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table PerkinElmer Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table PerkinElmer Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table BodiTech Company Details

    • Table BodiTech Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table BodiTech Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table BodiTech Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table Roche Company Details

    • Table Roche Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table Roche Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table Tosoh Company Details

    • Table Tosoh Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tosoh Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table Tosoh Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table DiaSorin Company Details

    • Table DiaSorin Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table DiaSorin Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table DiaSorin Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table Mediwatch (LABORIE) Company Details

    • Table Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table Siemens Healthcare Company Details

    • Table Siemens Healthcare Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table Ortho Clinical Company Details

    • Table Ortho Clinical Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ortho Clinical Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table Ortho Clinical Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table Beckman Coulter Company Details

    • Table Beckman Coulter Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beckman Coulter Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table Beckman Coulter Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table Fujirebio Company Details

    • Table Fujirebio Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fujirebio Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table Fujirebio Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Prostate-Specific Antigen (PSA) Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Prostate-Specific Antigen (PSA) Test Main Business and Markets Served

    • Table Abbott Prostate-Specific Antigen (PSA) Test Product Portfolio

    • Figure Global CLIA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ELISA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Post-treatment Monitoring Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Test Consumption Forecast by Country (2022-2028)

    • Table North America Prostate-Specific Antigen (PSA) Test Consumption Forecast by Country (2022-2028)

    • Figure United States Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prostate-Specific Antigen (PSA) Test Consumption Forecast by Country (2022-2028)

    • Figure Germany Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Prostate-Specific Antigen (PSA) Test Consumption Forecast by Country (2022-2028)

    • Figure China Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Prostate-Specific Antigen (PSA) Test Consumption Forecast by Country (2022-2028)

    • Figure Brazil Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Prostate-Specific Antigen (PSA) Test Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Prostate-Specific Antigen (PSA) Test Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Prostate-Specific Antigen (PSA) Test Consumption Forecast by Country (2022-2028)

    • Figure Australia Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Prostate-Specific Antigen (PSA) Test Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US